Make information easier to explore
Study how clinical indicators might be organised into a clear, transparent research workflow.
UpLift21 is an early-stage research concept exploring how machine learning and selected clinical indicators might support more informed conversations about prenatal screening.
An exploration of how data and responsible AI might support care—not replace it.
Prenatal screening involves complex information and important personal decisions. UpLift21 explores whether machine learning could help organise selected clinical indicators in a way that supports—not replaces—qualified healthcare professionals.
Study how clinical indicators might be organised into a clear, transparent research workflow.
Consider accessibility and resource constraints when exploring possible future digital health tools.
Protect informed choice, clinical judgement, counselling, and appropriate follow-up care.
Explore how a responsible interface might communicate data completeness, privacy, and possible next steps. This demonstration does not use patient data or make predictions.
This is an interface prototype only. It calculates no risk score, estimates no condition, and provides no clinical recommendation.
The project has explored a gradient-boosting ensemble using seven clinical biomarkers. This description does not establish clinical validity, safety, generalisability, or readiness for deployment.
No clinical performance figures or patient outcomes are claimed here.
Any potential medical use would require robust evaluation, independent review, and appropriate clinical and regulatory oversight.
Be specific about the research question, setting, and limits.
Evaluate with appropriate datasets and transparent methods.
Study data gaps, bias, and performance across relevant populations.
Use strong privacy safeguards and suitable clinical oversight.
Exploring how applied machine learning can be investigated responsibly in healthcare, with attention to accessibility, evidence, and limitations.
Confirm current project roles and obtain permission before publishing additional names, affiliations, or collaborator claims.
For project enquiries, reach out by email.